ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Vanda Pharmaceuticals (VNDA) Technical (Analysis) Reports Vanda Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Vanda Pharmaceuticals (VNDA)

Technical Analysis Report for NASDAQ stock VNDA Vanda Pharmaceuticals. Dated: 31 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock VNDA Vanda Pharmaceuticals then click here. or read Experts views on Vanda Pharmaceuticals or Forecast & share price targets of Vanda Pharmaceuticals

Vanda Pharmaceuticals Opened at 5.16 and Closed at: 5.10, which is -1.57% of previous session's close. It moved within a range of 4.95 and 5.16
The session was a Bearish session with an average volume of 540600, which is -83.13% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.

Support for tomorrow is 4.92 and resistance for tomorrow is 5.13
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 4.98, 4.86 resistance for tomorrow's hourly charts is 5.19, 5.28

10 Day SMA for Vanda Pharmaceuticals (VNDA) is 5.23 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Vanda Pharmaceuticals (VNDA) is 5.59 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Vanda Pharmaceuticals (VNDA) is 5.89 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 6.52 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Vanda Pharmaceuticals is 6.52 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Vanda Pharmaceuticals is at 5.59 and 200 DMA is at 6.52, while 50 DMA and 100 DMA are at 5.89 and 6.52 respectively

Vanda Pharmaceuticals (VNDA) moving average of 20 SMA is at 5.59 and 20 EMA is at 5.47

Vanda Pharmaceuticals (VNDA) moving average of 50 SMA is at 5.89 and 50 EMA is at 5.85

Vanda Pharmaceuticals (VNDA) moving average of 100 SMA is at 6.52 and 100 EMA is at 6.25

Vanda Pharmaceuticals (VNDA) moving average of 200 SMA is at 6.52 and 200 EMA is at 6.24

Vanda Pharmaceuticals has performed better than Viking Therapeutics in short term. Holding Vanda Pharmaceuticals could be a better choice for now!

Theravance Biopharma has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Theravance Biopharma, about 19.31% more returns!

Vanda Pharmaceuticals has performed better than Spero Therapeutics in short term. Holding Vanda Pharmaceuticals could be a better choice for now!

Vanda Pharmaceuticals has performed better than Ptc Therapeutics in short term. Holding Vanda Pharmaceuticals could be a better choice for now!

Mesoblast has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Mesoblast, about 19.35% more returns!

Atyr Pharma has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Atyr Pharma, about 25.18% more returns!

Adma Biologics has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Adma Biologics, about 12.05% more returns!

Ardelyx Inc has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Ardelyx Inc, about 12.2% more returns!

Atara Biotherapeutics has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Atara Biotherapeutics, about 1.87% more returns!

Biogen Inc has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Biogen Inc, about 18.85% more returns!

Cue Biopharma has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Cue Biopharma, about 0.57% more returns!

Dexcom Inc has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Dexcom Inc, about 33.62% more returns!

Enanta Pharmaceuticals has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Enanta Pharmaceuticals, about 8.49% more returns!

Vanda Pharmaceuticals has performed better than Fulgent Genetics in short term. Holding Vanda Pharmaceuticals could be a better choice for now!

Inogen Inc has performed better than Vanda Pharmaceuticals in short term. You could have earned much better returns by investing in Inogen Inc, about 18.81% more returns!

Vanda Pharmaceuticals Technical analysis of indicators

Price action analysis of Vanda Pharmaceuticals (VNDA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Vanda Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Vanda Pharmaceuticals in short term and the sell signal is strong.

Vanda Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Vanda Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Vanda Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 5.23 and Vanda Pharmaceuticals VNDA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Vanda Pharmaceuticals VNDA stock. Volume based technical analysis of Vanda Pharmaceuticals VNDA stock is negative.

Vanda Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock VNDA Vanda Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And VNDA Experts View which covers a lot of information including buying and selling signals

VNDA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Vanda Pharmaceuticals or View Candle Stick Charts here

Chart Vanda Pharmaceuticals (VNDA)  Technical (Analysis) Reports Vanda Pharmaceuticals [

Videos related to: Vanda Pharmaceuticals (VNDA) Technical (Analysis) Reports Vanda Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Vanda Pharmaceuticals (VNDA)  Technical (Analysis) Reports Vanda Pharmaceuticals [

 

Back to top